Articles

Copper Status in Patients with Thalassemia Major in Zahedan, Iran

Abstract

Introduction: There have been many reports and papers on deficient, normal and high levels of copper in patients with thalassemia major. The aim of this study is to evaluate copper status in a series of more than 300 patients with thalassemia major and determine the degree of copper deficiency or excess.
Methods: Three hundred and seventy patients with thalassemia major over 5 years of age were enrolled in this study. All patients were asked to fast for 12 hours before the test. Measurement was performed using atomic-absorption spectrophotometer in 2012 in southeast of Iran.
Results: The study included both males (n=192) and females (n=141). Of whom, 90 (27%) were aged 5-10 yrs, 80 (24%) were aged 10-15 yrs and 49% were above 15 years of age. Iron chelation therapy was dessferroxamine, deferasirox and dessferroxamine and deferiprone combinations in 61.5 %( 204 cases), 24.2%( 82 cases) and 14.3%( 47 cases), respectively. Among the 370 cases, 107 (32.1%) had copper deficiency, 73 (21.9%) had copper excess and 153 (45.9%) had normal copper level.
Conclusion: High percentage of copper deficiency was documented in 333 patients with thalassemia major and about 50% of patients had normal copper level. This finding showed the importance of micronutrient measurement in thalassemic patients for treatment planning in every part of the world.

Weatherall DJ. Thalassemia: The long road from bedside to genome. Nat Rev Genet 2004; 5:625-631.

Quirolo K, Vichinnky E. hemoglobin disorders in: Behrman Re. Nelson textbook of pediatrics. 18th ed.Philadelphia; Saunders.2007; PP: 2033-9

Merat A, Haghshenas M. The spectrum of beta thalassemia mutations in Iran. Med J Iran 2000; 14(2):103-106

Azizi F, Hatami H, Janghorbani M. Epidemiology and control of common diseases in Iran. Tehran; Khosravi Publisher. 2004; Pp: 254-62. (In Persian)

Habibzadeh F, Yadollahie M, Merat A. Thalassemia in Iran, an overview. Arch Inter Med. 1998; 7(1):27-33

Saka N, sukur M, Bundak R. Growth and puberty in thalassemia major. J Pediatr Endocinol metab. 1995; 8(3):181-6

Susan Claster, John C. Wood, Leila Noetzli, Susan M. Carson, Thomas C. Hofstra Rachna Khanna and Thomas D. Coates. Nutritional deficiencies in iron overloaded patients with hemoglobinopathies. Am J Hematol. 2009 June; 84(6): 344–348

Segal JB, Miller ER III, Brereton NH, Resar LM. Concentrations of B vitamins and homocysteine in with sickle cell anemia. South Med J 2004; 97:149–155

Cesar G. Fraga. Review Relevance, essentiality and toxicity of trace elements in human health. Molecular Aspects of Medicine 2005; 26:235–244

Tangney CC, Phillips G, Bell RA. Selected indices of micronutrient status in adult patients with sickle cell anemia (SCA). Am J Hematol 1989; 32:161–166

Haghshenas M, Zamani J. Thalassemia. Shiraz; Shiraz Medical University Publisher. 1997; Pp: 10-30. (In Persian)

Kanumakala, S., Boneh, A., Zacharin, M., 2002. Pamidronate treatment improves bone mineral density in Children with Menkes disease. J. Inherit. Metab. Dis. 25, 391–398.

Food and Nutrition Board, 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academy Press, Washington, DC.

Anderson JB. Minerals. In: KL Escott-Stump, S Krause, S Food, Nutrition and Diet therapy. 11th ed. Philadelphia; Sunders. 2004; Pp: 134-54

Mahyar A. The preventive role of zinc from communicable and non-communicable diseases in children. NCD Malaysia. 2005; 4(2):21-6.

Shamshirsaz AA, Bekheirnia MR, Kamgar S, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord. 2003; 3(1):4.

Kajanachumpol S, Tatu T, Sasanakul W, et al. Zinc and copper status of thalassemia children. Southeast Asian J Trop Med Public Health. 1997; 28(4):877-80.

Kamal Mansi, Talal Aburjaei, Moussa Baraqawi, Hamzeh Naser. Copper and Zinc status in Jordanian patients with thalassemia major treated with Desferal. Research journal of Biological sciences.2009; 4(5):566-57

Mahyar A, Ayazi P , Pahlevan A, Mojabi H, Sehhat M R and Javadi A. Zinc and Copper Status in Children with Beta-Thalassemia Major. Iran J Pediatr. 2010; 20 (3): 297-302

Nasr M.R, Ali S, Shaker M, Elgabry2 E. Antioxidant micronutrients in children with thalassaemia in Egypt. Eastern Mediterranean Health Journal.2002;8(4)

CAI Min-nin, HUANG Yu-jun, WU Shao-guo, OU Xiao-bing. Study on some element levels of thalassema with different genotype. Journal of Clinical Hematology 2011;1

Canellas C.G.L, Carvalho S.M.F, Anjos M.J, Lopes R.T. Determination of Cu/Zn and Fe in human serum of patients with sickle cell anemia using radiation synchrotron. Applied Radiation and Isotopes .2012; 70:1277–1280

Ellen B. Fung. Nutritional deficiencies in patients with thalassemia. Ann. N.Y. Acad. Sci. 2010; 1202:188–196

Files
IssueVol 7, No 3 (2013) QRcode
SectionArticles
Keywords
Copper Major thalassemia

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mashhadi MA. Copper Status in Patients with Thalassemia Major in Zahedan, Iran. Int J Hematol Oncol Stem Cell Res. 1;7(3):21-24.